Arindon, Princess Bella T.

HRN: 23-15-61  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2023
OXACILLIN 500MG (VIAL)
06/14/2023
06/20/2023
IV
935mg
Q6
Erysipelas Vs Cellulitis Right Leg
Waiting Final Action 
06/14/2023
CEFUROXIME 750MG (VIAL)
06/14/2023
06/20/2023
IV DRIP
400 Mg
Q8
UTI
Waiting Final Action 
06/15/2023
MUPIROCIN 2%, 15G (TUBE)
06/15/2023
06/21/2023
TOPICAL
On Affected Ared
TID
Erysipelas
Waiting Final Action 
06/16/2023
CEFTRIAXONE 1G (VIAL)
06/16/2023
06/23/2023
IV
1g
OD
Erysipelas
Waiting Final Action 
06/16/2023
CEFTRIAXONE 1G (VIAL)
06/16/2023
06/23/2023
IV
1g
OD
Erysipelas
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: